Biomarkers in Chronic Obstructive Pulmonary Disease: Emerging Roles of Eosinophils and Procalcitonin

Keyphrases

• Randomized Controlled Trial 100%
• Eosinophils 100%
• Chronic Obstructive Pulmonary Disease 100%
• Procalcitonin 100%
• Diabetes 50%
• Meta-analysis 50%
• Leukocytes 50%
• Antibiotics 50%
• Osteoporosis 50%
• Treatment Modalities 50%
• Increased Demand 50%
• Clinical Evidence 50%
• Blood Biomarkers 50%
• Clinical Decisions 50%
• Muscle Loss 50%
• Clinical Analysis 50%
• Safer Method 50%
• Politicians 50%
• Expected Effect 50%
• Serious Adverse Effects 50%
• Eosinophilic Granulocyte 50%
• Systemic Corticosteroids 50%
• Acute Exacerbation of COPD (AECOPD) 50%
• Bacterial Resistance 50%
• Severe Adverse Effects 50%
• Antibiotic Overuse 50%
• Gastrointestinal Infection 50%
• First Do No Harm 50%
• Primum Non Nocere 50%

Medicine and Dentistry

• Biological Marker 100%
• Chronic Obstructive Pulmonary Disease 100%
• Eosinophil 100%
• Procalcitonin 100%
• Adverse Event 50%
• Randomized Controlled Trial 50%
• Antibiotics 50%
• Leukocyte 25%
• Drug Therapy 25%
• Symptom 25%
• Diabetes 25%
• Meta-Analysis 25%
• Medicine 25%
• Corticosteroid 25%
• Osteoporosis 25%
• Granulocyte 25%
• Antibiotic Resistance 25%
• Gastrointestinal Infection 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Biological Marker 100%
• Chronic Obstructive Lung Disease 100%
• Procalcitonin 100%
• Adverse Event 50%
• Randomized Controlled Trial 50%
• Antibiotic Agent 50%
• Symptom 25%
• Corticosteroid 25%
• Gastrointestinal Infection 25%